U.S Markets Rise as Gilead Data Offsets Virus Fears
Gilead’s (GILD.O) remdesivir significantly improved clinical recovery and reduced the risk of death in COVID-19 patients, additional data from a late-stage study showed.
Read moreDetailsGilead’s (GILD.O) remdesivir significantly improved clinical recovery and reduced the risk of death in COVID-19 patients, additional data from a late-stage study showed.
Read moreDetailsThe secondary bond market on the Nairobi Securities Exchange recorded a decline in activity with bonds worth Kes 1.26 Billion achieved in 52 deals on the market as compared to the Kes 2.68 Billion achieved in 88 deals...
Read moreDetailsMembers of the Advisory Council play a critical role of looking into progress and constraints to gender equality globally and providing feedback and guidance of the bank’s work on gender equality and women’s voice.
Read moreDetailsGlobal benchmark Brent traded down 1.61% at $41.67 while U.S. crude fell 1.89% to $38.87 a barrel.
Read moreDetailsDeclining issues outnumbered advancing ones on the NYSE by a 2.63-to-1 ratio; on Nasdaq, a 2.09-to-1 ratio favored decliners.
Read moreDetails© 2025 The Trading Room Limited.